title: Antagonism of pancuronium and tubocurarine blocks by edrophonium or neostigmine: a comparative study.
abstract: Edrophonium 0.5 and neostigmine 0.05 mg kg-1 were compared as antagonists of pancuronium and tubocurarine-induced neuromuscular blocks, at varying degrees of recovery, in groups of 20 patients each. Adequate antagonism was defined as attaining a sustained train-of-four (TOF) ratio of 0.7 or more. Administration of edrophonium was associated with a more rapid onset of action (17 s with both relaxants with edrophonium, and 31 s and 29 s with neostigmine with pancuronium and tubocurarine, respectively), and a shorter time to attain a TOF ratio of 0.7 (74 s and 48 s with edrophonium and 230 s and 293 s with neostigmine for pancuronium and tubocurarine blocks, respectively). However, whereas neostigmine administration provided adequate antagonism in all 20 patients given pancuronium and in 19 out of 20 patients given tubocurarine, edrophonium failed to achieve adequate antagonism in six patients after pancuronium and eight patients after tubocurarine. The majority of these patients had shown three or less responses to a TOF stimulation prior to antagonism. Two separate groups of 10 patients each with relatively deeper pancuronium or tubocurarine blocks (three or less responses to TOF stimulation) were given edrophonium in a dose of 1.0 mg kg-1. However, adequate antagonism even with this dose of edrophonium was attained in only two out of 10 patients given pancuronium and in five out of 10 patients given tubocurarine. It is concluded that edrophonium is unreliable for antagonism of relatively deep blocks by pancuronium or tubocurarine and that neostigmine is the preferred and more reliable antagonist.
authors.affiliation: Department of Clinical Anaesthesia, Royal Victoria Hospital, Belfast, Ireland.
authors.forename: R K
authors.initials: RK
authors.lastname: Mirakhur
mesh_terms: D000328:Adult; D004491:Edrophonium / Q000494:pharmacology*; D006801:Humans; D008875:Middle Aged; D009388:Neostigmine / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D010197:Pancuronium / Q000037:antagonists & inhibitors*; D014403:Tubocurarine / Q000037:antagonists & inhibitors*
chemical_list: D009388:Neostigmine; D004491:Edrophonium; D010197:Pancuronium; D014403:Tubocurarine